null

SMILES: FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1

InChI Key: InChIKey=ZVHPDMQTWUUYIB-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 314969   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Orexin/Hypocretin receptor type 1 (Rattus norvegicus (Rat))	BDBM314969 ((2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifl...) Show SMILES FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| Show InChI InChI=1S/C23H20F3N5O/c24-23(25,26)15-6-7-20(29-12-15)30-18-10-14-11-19(18)31(13-14)22(32)17-5-2-1-4-16(17)21-27-8-3-9-28-21/h1-9,12,14,18-19H,10-11,13H2,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description Human Embryonic Kidney 293 cells (HEK293) stably expressing rat orexin 1 receptor (Genebank accession number NM_001525) or Chinese ovary cells (CHO) ...				US Patent US10183953 (2019) BindingDB Entry DOI: 10.7270/Q2Z60R5Q
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Rattus norvegicus (Rat))	BDBM314969 ((2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifl...) Show SMILES FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| Show InChI InChI=1S/C23H20F3N5O/c24-23(25,26)15-6-7-20(29-12-15)30-18-10-14-11-19(18)31(13-14)22(32)17-5-2-1-4-16(17)21-27-8-3-9-28-21/h1-9,12,14,18-19H,10-11,13H2,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description Human Embryonic Kidney 293 cells (HEK293) stably expressing rat orexin 1 receptor (Genebank accession number NM_001525) or Chinese ovary cells (CHO) ...				US Patent US9611277 (2017) BindingDB Entry DOI: 10.7270/Q24B33D2
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human))	BDBM314969 ((2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifl...) Show SMILES FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| Show InChI InChI=1S/C23H20F3N5O/c24-23(25,26)15-6-7-20(29-12-15)30-18-10-14-11-19(18)31(13-14)22(32)17-5-2-1-4-16(17)21-27-8-3-9-28-21/h1-9,12,14,18-19H,10-11,13H2,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description HEK293 stably expressing human orexin 2 receptor (Genebank accession number NM_001526) were grown to confluency in DMEM (Hyclone, cat # SH30022), 10%...				US Patent US9611277 (2017) BindingDB Entry DOI: 10.7270/Q24B33D2
					More data for this Ligand-Target Pair
Orexin/Hypocretin receptor type 1 (Homo sapiens (Human))	BDBM314969 ((2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifl...) Show SMILES FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| Show InChI InChI=1S/C23H20F3N5O/c24-23(25,26)15-6-7-20(29-12-15)30-18-10-14-11-19(18)31(13-14)22(32)17-5-2-1-4-16(17)21-27-8-3-9-28-21/h1-9,12,14,18-19H,10-11,13H2,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description CHO cells stably transfected with the human orexin 1 receptor (Genebank accession number NM_001526) were grown to confluency in DMEM/F12, 10% FBS, 1×...				US Patent US10183953 (2019) BindingDB Entry DOI: 10.7270/Q2Z60R5Q
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM314969 ((2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifl...) Show SMILES FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| Show InChI InChI=1S/C23H20F3N5O/c24-23(25,26)15-6-7-20(29-12-15)30-18-10-14-11-19(18)31(13-14)22(32)17-5-2-1-4-16(17)21-27-8-3-9-28-21/h1-9,12,14,18-19H,10-11,13H2,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	189	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description HEK293 stably expressing human orexin 2 receptor (Genebank accession number NM_001526) were grown to confluency in DMEM (Hyclone, cat # SH30022), 10%...				US Patent US9611277 (2017) BindingDB Entry DOI: 10.7270/Q24B33D2
					More data for this Ligand-Target Pair
Orexin receptor type 2 (Homo sapiens (Human))	BDBM314969 ((2-(pyrimidin-2-yl)phenyl)((1S,4S,6R)-6-((5-(trifl...) Show SMILES FC(F)(F)c1ccc(NC2CC3CC2N(C3)C(=O)c2ccccc2-c2ncccn2)nc1 |TLB:16:14:9.10:12,THB:8:9:14.15:12| Show InChI InChI=1S/C23H20F3N5O/c24-23(25,26)15-6-7-20(29-12-15)30-18-10-14-11-19(18)31(13-14)22(32)17-5-2-1-4-16(17)21-27-8-3-9-28-21/h1-9,12,14,18-19H,10-11,13H2,(H,29,30)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	189	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description PFSK-1 cells endogenously expressing the human orexin 2 receptor were grown to confluency in RPMI1640 (Hyclone, cat #30027.02), 10% FBS, 1× pen-strep...				US Patent US10183953 (2019) BindingDB Entry DOI: 10.7270/Q2Z60R5Q
					More data for this Ligand-Target Pair